Esperion Therapeutics Eulerpool Ziņas

Esperion Therapeutics Eulerpool News

Esperion Therapeutics Akciju Ziņas

Esperion Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Esperion Therapeutics ziņas mēs apkopojam šeit.

• 11. septembris ·

  Yahoo
  Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
• 5. septembris ·

  Yahoo
  Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
• 4. septembris ·

  Stock Options Channel
  Commit To Purchase Esperion Therapeutics At $1.50, Earn 36% Annualized Using Options
• 3. septembris ·

  Yahoo
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
• 3. septembris ·

  TipRanks
  Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential
• 3. septembris ·

  GlobeNewswire
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL? (bempedoic acid) and NEXLIZET? (bempedoic acid and ezetimibe)
• 3. septembris ·

  Thefly.com
  Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL
• 26. augusts ·

  Yahoo
  Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
• 19. augusts ·

  SeekingAlpha
  Esperion Therapeutics: Delivering On Expectations While Navigating Overhangs
• 16. augusts ·

  SeekingAlpha
  Esperion Therapeutics: Strategically Positioned To Grow